# California BanCorp \\ CA: overview BCAL · Nasdaq · CIK 1795815 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/bcal.md) · [Financials](/companies/bcal/financials.md) · [Filings](/companies/bcal/filings.md) · [Insiders](/companies/bcal/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(0.59)](/filings/0001795815-25-000021.md) | not reported | [0.52](/filings/0001795815-26-000015.md) | [0.43](/filings/0001795815-26-000018.md) | [0.48](/filings/0001795815-25-000021.md) | not reported | [0.42](/filings/0001795815-26-000015.md) | [0.44](/filings/0001795815-26-000018.md) | | Free cash flow | $m | [18.1 d](/filings/0001795815-25-000021.md) | [23.5 d](/filings/0001795815-26-000005.md) | [6.9](/filings/0001795815-26-000015.md) | [13.4 d](/filings/0001795815-26-000018.md) | [15.9 d](/filings/0001795815-25-000021.md) | [20.8 d](/filings/0001795815-26-000005.md) | [8.3](/filings/0001795815-26-000015.md) | [14.3 d](/filings/0001795815-26-000018.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.88](/filings/0001628280-24-011472.md) | [1.39](/filings/0001628280-25-015957.md) | [0.22](/filings/0001795815-26-000005.md) | [1.93](/filings/0001795815-26-000005.md) | | Free cash flow | $m | [12.3](/filings/0001628280-24-011472.md) | [32.8](/filings/0001628280-25-015957.md) | [49.7](/filings/0001795815-26-000005.md) | [56.9](/filings/0001795815-26-000005.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bcal/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $51.0m | 2,447,278 | | Reduced −240,206 | | [FJ Capital Management LLC](/funds/1599170.md) | 2026-06-30 | $42.8m | 2,054,534 | | Unchanged | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $40.1m | 1,925,599 | | Added +467,195 | | [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $34.6m | 1,952,131 | | Reduced −196,265 | | [ENDEAVOUR CAPITAL ADVISORS INC](/funds/1218749.md) | 2026-06-30 | $34.5m | 1,655,639 | | Reduced −163,486 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $23.0m | 1,104,260 | | Added +58,473 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $17.8m | 850,362 | | Added +80,312 | | [BANC FUNDS CO LLC](/funds/1029311.md) | 2026-06-30 | $17.0m | 816,155 | | Reduced −15,000 | | [MANUFACTURERS LIFE INSURANCE COMPANY, THE](/funds/928047.md) | 2026-06-30 | $16.5m | 791,794 | | Reduced −3,515 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $13.2m | 631,917 | | Added +76,111 | ## Recent filings [All 355 filings](/companies/bcal/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-28 | 08:05 ET | [8-K](/filings/0001493152-26-048825.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-048825 | | 2026-08-07 | 16:15 ET | [10-Q](/filings/0001795815-26-000018.md) | Quarterly report, period 2026-06-30 | 0001795815-26-000018 | | 2026-07-27 | 08:10 ET | [8-K](/filings/0001493152-26-034705.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-034705 | | 2026-05-28 | 08:10 ET | [8-K](/filings/0001493152-26-025541.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-025541 | | 2026-05-08 | 16:10 ET | [10-Q](/filings/0001795815-26-000015.md) | Quarterly report, period 2026-03-31 | 0001795815-26-000015 | | 2026-05-05 | 19:09 ET | [8-K](/filings/0001493152-26-021177.md) | 7.01 Regulation FD disclosure | 0001493152-26-021177 | | 2026-04-28 | 08:05 ET | [8-K](/filings/0001493152-26-019246.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-019246 | | 2026-04-14 | 16:41 ET | [DEF 14A](/filings/0001795815-26-000012.md) | Proxy statement, period 2025-12-31 | 0001795815-26-000012 | | 2026-03-13 | 17:23 ET | [10-K](/filings/0001795815-26-000005.md) | Annual report, period 2025-12-31 | 0001795815-26-000005 | | 2026-03-12 | 16:35 ET | [8-K](/filings/0001493152-26-009873.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-009873 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001795815-26-000005.md), filed Mar 13, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1795815 - Tickers: BCAL - Exchange: Nasdaq - SIC code: 6021 National Commercial Banks - State of incorporation: CA - Filer category: Accelerated filer
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 28, 2026, 08:06 ET. No prices; not investment advice.